Publications by authors named "F L Basiye"
Background: HIV low-level viremia (LLV) (51-999 copies/mL) can progress to treatment failure and increase potential for drug resistance. We analyzed retrospective longitudinal data from people living with HIV (PLHIV) on antiretroviral therapy (ART) in Kenya to understand LLV prevalence and virologic outcomes.
Methods: We calculated rates of virologic suppression (≤50 copies/mL), LLV (51-999 copies/mL), virologic non-suppression (≥1000 copies/mL), and virologic failure (≥2 consecutive virologic non-suppression results) among PLHIV aged 15 years and older who received at least 24 weeks of ART during 2015-2021.
Article Synopsis
- PEPFAR supports diagnostic networks for HIV and tuberculosis in low and middle-income countries, which were leveraged for SARS-CoV-2 testing during the COVID-19 pandemic.
- From April 2020 to March 2021, 27 countries reported on the use of these networks, with a focus on 46 key indicators for COVID-19 response activities.
- Overall, participating labs contributed to over 3.4 million SARS-CoV-2 tests, demonstrating the effectiveness of PEPFAR resources in emergency health responses.
Background: Since 2010, Kenya has used SLIPTA to prepare and improve quality management systems in medical laboratories to achieve ISO 15189 accreditation. However, less than 10% of enrolled laboratories had done so in the initial seven years of SLMTA implementation.
Objective: We described Kenya's experience in accelerating medical laboratories on SLMTA to attain ISO 15189 accreditation.
One component of the Joint United Nations Programme on HIV/AIDS (UNAIDS) goal to end the HIV/AIDS epidemic by 2030, is that 95% of all persons receiving antiretroviral therapy (ART) achieve viral suppression. Thus, testing all HIV-positive persons for viral load (number of copies of viral RNA per mL) is a global health priority (1). CDC and other U.
View Article and Find Full Text PDFAssessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
Int J Tuberc Lung Dis
November 2015
Setting: Drug susceptibility testing (DST) is recommended in Kenya to identify multidrug-resistant tuberculosis (MDR-TB) in persons registered for tuberculosis (TB) retreatment. DST is performed at a central laboratory with a two-step growth-based process and a regional laboratory with a simultaneous molecular- and growth-based process.
Objective: To compare proportions of retreatment cases who underwent DST and turnaround times for hospitals referring to the central vs.